Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,182.70
2,877.40
2,327.50
1,936.30
1,685.50
1,483.30
1,448.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,182.70
2,877.40
2,327.50
1,936.30
1,685.50
1,483.30
1,448.80
Raw Material Cost
384.40
309.70
257.50
151.60
122.50
108.10
117.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.50
42.90
59.30
32.40
18.60
23.50
44.20
Selling and Distribution Expenses
731.10
709.70
473.50
470.90
464.50
423.90
336.20
Other Expenses
53.05
43.81
34.87
29.05
39.14
32.88
32.96
Total Expenditure (Excl Depreciation)
1,665.50
1,500.40
1,139.00
945.40
997.00
884.30
827.60
Operating Profit (PBDIT) excl Other Income
1517.2
1377
1188.5
990.9000000000001
688.5
599
621.1999999999999
Other Income
197.90
204.90
148.70
5.00
58.90
54.30
45.40
Operating Profit (PBDIT)
1,800.70
1,654.40
1,390.40
1,047.20
797.30
703.20
712.50
Interest
19.50
42.90
59.30
32.40
18.60
23.50
44.20
Exceptional Items
18.30
0.00
-3.60
-12.90
-134.90
9.10
-787.40
Gross Profit (PBDT)
2,798.30
2,567.70
2,070.00
1,784.70
1,563.00
1,375.20
1,331.20
Depreciation
85.60
72.50
53.20
51.30
49.90
49.90
45.90
Profit Before Tax
1,713.90
1,539.00
1,274.30
950.60
593.90
638.90
-165.00
Tax
379.20
343.90
289.50
223.30
118.10
124.10
-60.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,334.70
1,195.10
984.80
727.30
475.80
514.80
-104.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,334.70
1,195.10
984.80
727.30
475.80
514.80
-104.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,334.70
1,195.10
984.80
727.30
475.80
514.80
-104.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
7,096.20
6,444.00
5,984.80
4,796.70
3,958.90
3,395.20
2,780.40
Earnings per share (EPS)
27.86
24.64
19.81
15.0
10.06
11.54
-2.39
Diluted Earnings per share
27.86
24.64
19.81
15.0
10.06
11.54
-2.39
Operating Profit Margin (Excl OI)
47.67%
47.86%
51.06%
51.17%
40.85%
40.38%
42.88%
Gross Profit Margin
56.54%
56.01%
57.04%
51.74%
38.2%
46.44%
-8.22%
PAT Margin
41.94%
41.53%
42.31%
37.56%
28.23%
34.71%
-7.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 10.61% vs 23.63% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 11.68% vs 21.35% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 10.58% vs 16.74% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -54.55% vs -27.66% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of United Therapeutics Corp. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
3,182.70
2,860.50
322.20
11.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,182.70
2,860.50
322.20
11.26%
Raw Material Cost
384.40
52.10
332.30
637.81%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
19.50
0.00
19.50
Selling and Distribution Expenses
731.10
1,156.20
-425.10
-36.77%
Other Expenses
53.05
101.57
-48.52
-47.77%
Total Expenditure (Excl Depreciation)
1,665.50
2,224.00
-558.50
-25.11%
Operating Profit (PBDIT) excl Other Income
1,517.20
636.50
880.70
138.37%
Other Income
197.90
90.30
107.60
119.16%
Operating Profit (PBDIT)
1,800.70
756.90
1,043.80
137.90%
Interest
19.50
0.00
19.50
Exceptional Items
18.30
-21.40
39.70
185.51%
Gross Profit (PBDT)
2,798.30
2,808.40
-10.10
-0.36%
Depreciation
85.60
30.10
55.50
184.39%
Profit Before Tax
1,713.90
705.40
1,008.50
142.97%
Tax
379.20
226.80
152.40
67.20%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,334.70
478.60
856.10
178.88%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,334.70
478.60
856.10
178.88%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,334.70
478.60
856.10
178.88%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
7,096.20
3,253.10
3,843.10
118.14%
Earnings per share (EPS)
27.86
4.67
23.19
496.57%
Diluted Earnings per share
27.86
4.67
23.19
496.57%
Operating Profit Margin (Excl OI)
47.67%
22.25%
0.00
25.42%
Gross Profit Margin
56.54%
25.71%
0.00
30.83%
PAT Margin
41.94%
16.73%
0.00
25.21%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 318.27 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.61% vs 23.63% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 133.47 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 11.68% vs 21.35% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 160.28 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.58% vs 16.74% in Dec 2024
Annual - Interest
Interest 1.95 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -54.55% vs -27.66% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 47.67%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
